Blueprint Medicines Corp Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for December 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 0 | |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 125.00 | 5,455 | 681,875 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 5,455 | |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 120.00 | 5,454 | 654,480 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 19.53 | 10,909 | 213,053 | 0 | |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 117.82 | 10,909 | 1,285,298 | 3,562 | 14.5 K to 3.6 K (-75.39 %) |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 19.53 | 10,909 | 213,053 | 14,471 | 3.6 K to 14.5 K (+306.26 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 5,000 | 44,000 | 17,170 | |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 119.18 | 5,000 | 595,900 | 141,434 | 146.4 K to 141.4 K (-3.41 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 5,000 | 44,000 | 146,434 | 141.4 K to 146.4 K (+3.54 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 15.01 | 10,000 | 150,100 | 7,483 | |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 116.75 | 215 | 25,101 | 28,147 | 28.4 K to 28.1 K (-0.76 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 117.92 | 1,970 | 232,302 | 28,362 | 30.3 K to 28.4 K (-6.49 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 118.72 | 7,815 | 927,797 | 30,332 | 38.1 K to 30.3 K (-20.49 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 15.01 | 10,000 | 150,100 | 38,147 | 28.1 K to 38.1 K (+35.53 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 48,000 | |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 119.00 | 4,600 | 547,400 | 15,250 | 19.9 K to 15.3 K (-23.17 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 19,850 | 15.3 K to 19.9 K (+30.16 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 10,909 | |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 115.00 | 5,455 | 627,325 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 16,364 | |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 110.00 | 5,454 | 599,940 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 900 | 7,920 | 2,964 | |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 110.00 | 900 | 99,000 | 9,984 | 10.9 K to 10 K (-8.27 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 900 | 7,920 | 10,884 | 10 K to 10.9 K (+9.01 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 109.08 | 138 | 15,053 | 9,984 | 10.1 K to 10 K (-1.36 %) |